Knee Surgery - Xconomy

by in

Entry	Author	Date	Location
Omeros Bounces Back With Drug For Eye Surgeries; Shares Climb	Luke Timmerman	03/13/12	Seattle
Amp Orthopedics Takes Aim at Boomers’ Achy Knees and Shoulders	Luke Timmerman	02/16/12	Seattle
Pfizer and BMS Score Approval for Orthopedic Drug	Arlene Weintraub	05/20/11	New York
Omeros Fails in Pivotal Trials With Drug for Knee Surgery, Stock Crashes	Luke Timmerman	03/31/11	Seattle
Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets	Luke Timmerman	11/19/09	Seattle
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day	Luke Timmerman	10/08/09	Seattle
Omeros Raises $68.2M in Washington’s First IPO in Two Years	Luke Timmerman	10/08/09	Seattle
Omeros Teed Up for IPO Next Week, Seeking to Rake In More Than $80M	Luke Timmerman	10/02/09	Seattle
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News	Luke Timmerman	09/17/09	Seattle
Omeros Moves Closer To IPO, Sets Price Goal	Luke Timmerman	09/16/09	Seattle
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say	Luke Timmerman	08/26/09	Seattle
OrthAlign Raises $7.2M	Luke Timmerman	01/07/09	San Diego
Omeros, Developer of Knee-Surgery Enhancer, Raises $20 Million in Debt Financing	Luke Timmerman	09/25/08	Seattle
ConforMIS Introduces Third Implant for Arthritic Knees	Luke Timmerman	08/04/08	Boston
Page 1 of 1

Xconomy National